Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 DeFi Kingdoms DeFi Kingdoms +1,091.73%
#4 Black Phoenix Black Phoenix +334.12%
#5 aPriori aPriori +117.17%
#6 Bedrock Bedrock +70.28%
#7 Prom Prom +40.32%
#8 Cysic Cysic +39.09%
#9 COTI COTI +38.17%
#10 Playnance Playnance +34.56%
Coin of the day
Wrapped One Wrapped One
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
GlobeImmune, Inc. GlobeImmune, Inc.

GlobeImmune, Inc.

GBIM
Classifica tra le azioni #42634
GlobeImmune, Inc., a biopharmaceutical firm based in Louisville, Colorado, and... GlobeImmune, Inc., a biopharmaceutical firm based in Louisville, Colorado, and founded in 1995 (originally Ceres Pharmaceuticals, Inc. until its rebranding in May 2001), specializes in creating therapeutic products for both cancer and infectious diseases. Central to its development efforts is its unique Tarmogen platform. The company's pipeline includes several key candidates: For infectious diseases: GS-4774 is currently in Phase 2 clinical trials, designed to treat individuals chronically infected with the hepatitis B virus who are also on oral antiviral suppressive therapy. Additionally, GlobeImmune has various other infectious disease programs in the preclinical stage, such as GI-19000 for tuberculosis, GI-2010 for human immunodeficiency virus (HIV), and GI-18000 for hepatitis D virus infections. For oncology: GlobeImmune is advancing GI-6301, which targets cancers characterized by the expression of the brachyury protein. GI-6207 is progressing through Phase 2 clinical trials for medullary thyroid cancer. Furthermore, GI-4000 is a significant asset, undergoing Phase 2b clinical trials for resected pancreatic cancer, and is also in separate Phase 2 trials for non-small cell lung cancer and colorectal cancer. To support its endeavors, GlobeImmune maintains strategic alliances with industry leaders such as Gilead Sciences, Inc. and Celgene Corporation.
Prezzo delle azioni
$0.0001
Ultima sincronizzazione: 2026-08-11
Capitalizzazione di mercato
$575.00
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia GlobeImmune, Inc. (GBIM)

Categoria

Healthcare
Il prezzo GBIM con la capitalizzazione del mercato della B
GlobeImmune, Inc. GlobeImmune, Inc.
GBIM
$0.0001
Capitalizzazione di mercato di GlobeImmune, Inc.(GBIM)
Capitalizzazione di mercato: $575.00
A partire dal August 2026, GlobeImmune, Inc. ha una capitalizzazione di mercato pari a $575.00. Questo rende GlobeImmune, Inc. la 42634th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di GlobeImmune, Inc. dal 2014 al 2026
GBIM in paragone con la classifica dei più popolari stocks
Il prezzo per GBIM Attivo B Capitalizzazione del mercato a B Risultati
GlobeImmune, Inc. GlobeImmune, Inc.
$943,650 $575.00
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.426T +943,650,177,897.04%
GlobeImmune, Inc. GlobeImmune, Inc.
$769,898 $575.00
Apple Inc. Apple Inc.
AAPL
$4.427T +769,898,429,806.09%
GlobeImmune, Inc. GlobeImmune, Inc.
$719,817 $575.00
Alphabet Inc. Alphabet Inc.
GOOG
$4.139T +719,817,309,683.48%
GlobeImmune, Inc. GlobeImmune, Inc.
$635,834 $575.00
Microsoft Corporation Microsoft Corporation
MSFT
$3.656T +635,833,684,982.96%
GlobeImmune, Inc. GlobeImmune, Inc.
$501,851 $575.00
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.886T +501,851,453,900.00%